![Marc Grasso](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marc Grasso
Plus aucun poste en cours
Fortune : 639 516 $ au 31/05/2026
Profil
Marc Edward Grasso formerly worked at Morgan Stanley & Co. LLC, as Executive Director-Investment Banking, Leerink Partners LLC, as Managing Director from 2008 to 2010, Leerink Swann & Co., as Managing Director-Investment Banking from 2008 to 2010, Credit Suisse Securities (USA) LLC (Broker), as Vice President-Investment Banking, Stifel Financial Corp., as MD-Healthcare Investment Banking Group from 2013 to 2018, UBS Group AG, as MD-Investment Banking & Global Healthcare Group from 2010 to 2013, Kura Oncology, Inc., as Secretary, Chief Financial & Business Officer in 2019, Kyverna Therapeutics, Inc., as Chief Financial Officer & Accounting Officer from 2025 to 2026, and Alector, Inc., as Chief Financial Officer from 2022 to 2025.
Dr. Grasso received his undergraduate degree from Princeton University and doctorate degree from The Johns Hopkins University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALECTOR, INC. 0,27 % | 02/06/2025 | 296 072 ( 0,27 % ) | 639 516 $ | 31/05/2026 |
Anciens postes connus de Marc Grasso
| Sociétés | Poste | Fin |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Directeur Financier/CFO | 18/05/2026 |
| ALECTOR, INC. | Directeur Financier/CFO | 20/06/2025 |
| KURA ONCOLOGY, INC. | Directeur Financier/CFO | 04/02/2022 |
| STIFEL FINANCIAL CORP. | Corporate Officer/Principal | 01/07/2018 |
| UBS GROUP AG | Corporate Officer/Principal | 01/02/2013 |
Formation de Marc Grasso
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
58
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Credit Suisse Securities (USA) LLC (Broker)
 Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Stifel Financial Corp.
 Stifel Financial Corp. Investment ManagersFinance Operates as a bank holding company through its subsidiaries provides wealth and asset management, investment banking & trading services | Finance |
UBS Group AG
 UBS Group AG Investment ManagersFinance Provides private wealth management, advisory, investment and corporate banking & asset management services | Finance |
Kura Oncology, Inc.
 Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alector, Inc.
 Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leerink Swann & Co.
 Leerink Swann & Co. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Kyverna Therapeutics, Inc.
 Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
